The U.S. DEA classifies Vicodin as a schedule III drug - a low to moderate risk of physical dependence, but a high risk of psychological dependence.
About 1.3% of 8th graders and 3.8% of 12th graders had used it for a non-medicinal purpose in a 2012 survey. It is usually seized in pill form. However, abuse crosses all age groups and ethnic groups. In 2009 and 2010, hydrocodone was the second most frequently encountered opioid pharmaceutical in drug evidence submitted to U.S. Hydrocodone is abused for Hydrocodone diversion and abuse has escalated in recent years. It is also a major problem with high-school aged individuals.
On Friday, August 22, the U. S. Drug Enforcement Administration (DEA) published their Final Rule moving hydrocodone combination products.
Manufacturers and distributors must secure schedule II substances in a safe, steel cabinet or vault while schedule III substances may be stored in a less secure controlled substance cage or other enclosure. Several commenters suggested that it would cost millions of dollars for distributors and retail pharmacies to obtain new vaults or increase the size of their vaults to accommodate for the influx of HCPs. Another commenter suggested that only a limited number of firms can build vaults that meet the requirements of the DEA and because of this, constructing a vault would be time consuming and costly.
The paper orders represented roughly 27.7 million transactions (or about 6 per order); the electronic orders represented roughly 21.2 million transactions or slightly more than 23 per order.”.
(UPDATED) Last week, a Food and Drug Administration (FDA) advisory panel voted to impose stricter controls on prescriptions for drugs like.
The new rules would likely make it harder for those who rely on opioids to treat chronic pain for conditions like multiple sclerosis, fibromyalgia, certain genetic disorders and some severe injuries (the kind of pain that often lasts decades) to get their prescriptions filled. Many doctors already decline to treat chronic pain with opioids, fearing prosecution if some of their patients turn out to be addicted to the painkillers and are faking pain, or end up overdosing. Those who can get treatment are already subjected to random pill counts and urine tests to ensure they are taking their pills as directed and as needed.
Under the new rules, some patients may even lose access to treatment entirely because insurers may not cover the monthly doctor visits required for continued prescribing or because doctors may not want to deal with the added hassle.
A generic version of Vicodin, a powerful prescription painkiller, was the most widely prescribed drug to Medicare beneficiaries in 2013.
Many of those who took generic Vicodin were in the Medicare program because they were disabled, even if they were not 65 or older, according to the Medicare data. Among providers who wrote more than 10 prescriptions to both elderly and disabled beneficiaries, about 45% of the claims were for people under 65, the Journal ls us.
The Medicare data highlights how some prescribers prescribe the drug far more than others – even within the same specialty. Among family practitioners, most doctors wrote prescriptions for less than 20% of their Medicare patients, but a group of about 200 doctors gave the drug to more than half the Medicare beneficiaries for whom they wrote prescriptions, the Journal adds.
More than half of the prescriptions for the drug, which is generally known as hydrocodone acetaminophen, were written by family practice or internal medicine physicians – and these specialties represented nearly a quarter of the more than 1 million providers listed in the data from the U.S.
The L.A. Times reports that the DEA today is announcing a new rule that will tighten regulations on drugs containing hydrocodone, like Vicodin.
“…after the DEA showed that hydrocodone-containing drugs are all over the black market, the FDA reconsidered their position.”
Because we all know that Schedule I substances don’t exist on the black market.
Want to help? Request an invite. We are currently testing a new commenting system.
Times reports that the DEA today is announcing a new rule that will tighten regulations on drugs containing hydrocodone, like Vicodin. The new rule, which classifies them as Schedule II drugs, places them in the same category as other frequently-abused drugs like OxyContin.